2014 Annual Meeting | 2NF.002 - Neuro Flash: Acute Stroke Management

Date Sunday 04/27/14

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuro Flash

Director(s) Lawrence R. Wechsler, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with current controversies in acute stroke management and the contribution of the results of recent clinical trials to our understanding of the optimal treatment of acute stroke patients.

CME Available No CME available

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 AM - 07:00 AM		Advanced Imaging for Patient Selection in Acute Stroke Lawrence R. Wechsler, MD, FAAN
07:00 AM - 07:15 AM		Questions and Answers
07:15 AM - 07:45 AM		Endovascular Therapy for Acute Stroke: Is There Still a Role? Tudor G. Jovin, MD
07:45 AM - 08:00 AM		Questions and Answers

Faculty Disclosures
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Silk Road Medical. Dr. Wechsler has received stock or an ownership interest from Forest Devices. The institution of Dr. Wechsler has received research support from NINDS.
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.